|
![]() |
|||
|
||||
OverviewObesity has devastating effects on a patient's overall health, with specific negative effects on organ systems, long-term. The hepatologist must often manage diseases of the liver and pancreas as a result of obesity. This issue will provide a current update on the diagnosis, treatment, and management of NAFLD and NASH. Dr. Bernstein has assembled the top leaders in the field to provide timely clinical reviews. Articles are devoted to the following topics: Clinical and economic burden of NAFLD/NASH; NAFLD/NASH in children and its implications; Natural history of NAFLD/NASH; Diagnosis and evaluation of NAFLD/NASH; Radiological imaging in NAFLD/NASH; The use of liver biopsy in NAFLD: When to biopsy and in whom; Pathophysiology of NAFLD/NASH; Risk factors for the development of NAFLD/NASH including genetics; Role of intestinal microbes in NAFLD/NASH; NAFLD/NASH and the metabolic syndrome; NAFLD/NASH and lipid and insulin resistance; NAFLD/NASH and cardiac disease; Current treatment of NAFLD/NASH; Emerging treatment of NAFLD/NASH; NAFLD/NASH and HCC and NAFLD/NASH and liver transplantation. Readers will have a clear understanding of how to manage outcomes for these patients. Full Product DetailsAuthor: David Bernstein (Professor of Medicine, NYU Langone School of Medicine, Director, Gastroenterology and Hepatology Ambulatory Services, NYU Langone Health, New York, New York)Publisher: Elsevier - Health Sciences Division Imprint: Elsevier - Health Sciences Division Volume: 22-1 Weight: 0.540kg ISBN: 9780323569866ISBN 10: 0323569862 Publication Date: 03 January 2018 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsClinics in Liver Disease NASH and NAFLD Preface: Nonalcoholic Fatty Liver Disease: An Expanding Health Care Epidemic Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics The Genetics of Pediatric Nonalcoholic Fatty Liver Disease Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography Radiologic Imaging in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis The Use of Liver Biopsy in Nonalcoholic Fatty Liver Disease: When to Biopsy and in Whom The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease Nonalcoholic Fatty Liver Disease and Metabolic Syndrome The Role of Nonalcoholic Fatty Liver Disease on Cardiovascular Manifestations and Outcomes Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Emerging Treatments for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver TransplantationReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |